RE:OT: Details behind $5.7B Danaher acquisition of AbcamThanks for the informative posts Note, but i can't be the only one fed up with reading about every biotech not Oncy getting snatched up, right? I don't think many can preach patience to Oncy investors without being laughed outta the room. The SP languishes...the management underwhelms.